Welcome to Our Site
Our site provides investors with company-
specific data on publicy traded Israeli
stocks in Tel Aviv, Israeli companies
traded globally as well as up-to-date
information on Israel and its economy.
Globes, 18/3/2015 - Leumi to report NIS 290m profit on Mobileye share saleRead More >>
Bank Leumi also sold Mobileye shares in 2014, making profits of NIS 143 million and NIS 16 million.
Globes, 18/3/2015 - Teva teams with Ignyta on oncology treatmentRead More >>
Teva is selling four targeted oncology development programs to Ignyta for 6% of the biotech company.
Seeking Alpha, 17/3/2015 - Teva Pharmaceutical: Bold Markets, Bold MovesRead More >>
Globes, 16/3/2015 - Cellcom reports lower revenue, higher profitRead More >>
Cellcom CEO Nit Sztern: We'll have over 20,000 Cellcom tv subscribers by the end of March.
Bank Hapoalim - Corporate Movie
Teva - PM Cameron visit Teva
Strauss Group concludes 2014 with 4.2% organic sales growth excluding foreign currency impacts and 12.6% growth in net profit, thanks in part to income from the revaluation of currency hedging transactions  >>
Gazit-Globe to Report Fourth Quarter and Year-End 2014 Financial Results on March 24, 2015 >>
Elbit Systems U.S. Subsidiary Awarded a $73.4 Million USMC IDIQ Contract for Common Laser Range Finder - Integrated Capability >>
BrainStorm Cell Therapeutics
BrainStorm Cell Therapeutics to Report Fourth Quarter and Full Year 2014 Financial Results on Thursday, March 26 >>
Teva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from Teva >>
BioLineRx to Report Fourth Quarter and Year End 2014 Results on March 23, 2015 >>
Kamada Strengthens Leadership Team with the Addition of Vice President-Medical Director >>
BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares >>
Reprinted from the Equities Israel web site - www.equities.co.il